Home LiteratureArticle Details
PMID: 1717632 Published · ppublish English Journal Article Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, P.H.S.

Antigen-driven bystander suppression after oral administration of antigens.

The Journal of experimental medicine ·Vol. 174 ·No. 4 ·1991-10-01 ·Pages 791-8

Miller A, Lider O, Weiner HL

Abstract

Suppression of experimental autoimmune encephalomyelitis (EAE) in Lewis rats by the oral administration of myelin basic protein (MBP) is mediated by CD8+ T cells that can be isolated from the spleens of MBP-fed animals. These cells adoptively transfer protection to naive animals subsequently immunized with MBP and complete Freund's adjuvant (CFA) and suppress in vitro MBP proliferative responses. Using a transwell system in which the modulator spleen cells from MBP-fed animals are separated by a semipermeable membrane from responder cells, MBP, or OVA-specific T cell lines, we have found that cell contact is not required for in vitro suppression to occur. In vitro suppression is dependent, however, upon antigen-specific triggering of modulator T cells. Once antigen-specific triggering occurs, suppression across the transwell is mediated by an antigen-nonspecific soluble factor that equally suppresses an MBP line or an ovalbumin (OVA) line. This phenomenon of antigen-driven bystander suppression was also demonstrated in vivo. Specifically, Lewis rats fed OVA which were then immunized with MBP/CFA plus OVA given separately subcutaneously were protected from EAE. Animals fed OVA and then immunized with MBP/CFA without OVA given subcutaneously were not protected. The protective effect of feeding OVA could be adoptively transferred by CD8+ T cells from OVA-fed animals into MBP/CFA plus OVA-injected animals. Feeding bovine serum albumin (BSA) or keyhole limpet hemocyanin did not suppress EAE in animals immunized with MBP/CFA plus OVA. EAE was suppressed, however, if BSA was fed and animals then immunized with MBP/CFA plus BSA given subcutaneously. Antigen-driven bystander suppression appears to be an important mechanism by which antigen-driven peripheral tolerance after oral administration of antigen is mediated, and presumably occurs in the microenvironment accounting for the antigen specificity of suppression generated by oral tolerization to antigens.

MeSH Terms
Administration, Oral Animals Encephalomyelitis, Autoimmune, Experimental/immunology,prevention & control Female Guinea Pigs Hypersensitivity, Delayed Immunotherapy, Adoptive Myelin Basic Protein/administration & dosage,therapeutic use Ovalbumin/immunology Rats Rats, Inbred Lew Serum Albumin, Bovine/immunology Spleen/immunology T-Lymphocytes/immunology
Chemicals
Myelin Basic Protein Serum Albumin, Bovine Ovalbumin
Authors & Affiliations
3 authors, click to expand affiliations / ORCID
Miller A
Department of Medicine, Brigham and Women's Hospital, Boston, Massachusetts.
Lider O
Weiner H L
References (29)
29 references, click to expand
  1. Clonal anergy induced in mature V beta 6+ T lymphocytes on immunizing Mls-1b mice with Mls-1a expressing cells.
    Nature. 1989 Jun 15;339(6225):541-4 PMID: 2525232
  2. Present understanding of suppressor T cells.
    Res Immunol. 1989 Mar-Apr;140(3):291-4; discussion 339-45 PMID: 2474183
  3. The cytokine network.
    Immunol Today. 1989 Sep;10(9):299-304 PMID: 2686679
  4. Suppressor cells and immunoregulation.
    Annu Rev Immunol. 1984;2:127-57 PMID: 6242348
  5. T cell tolerance by clonal elimination in the thymus.
    Cell. 1987 Apr 24;49(2):273-80 PMID: 3494522
  6. Suppression of type II collagen-induced arthritis by intragastric administration of soluble type II collagen.
    Proc Natl Acad Sci U S A. 1986 Oct;83(19):7443-6 PMID: 3463976
  7. Gastric administration of type II collagen delays the onset and severity of collagen-induced arthritis in rats.
    Clin Exp Immunol. 1986 Jun;64(3):581-6 PMID: 3791692
  8. Competition between foreign and self proteins in antigen presentation. Ovalbumin can inhibit activation of myelin basic protein-specific T cells.
    J Immunol. 1990 Feb 15;144(4):1177-80 PMID: 1689345
  9. Inhibition of S-antigen induced experimental autoimmune uveoretinitis by oral induction of tolerance with S-antigen.
    J Immunol. 1990 Mar 1;144(5):1689-95 PMID: 2137841
  10. Administration of myelin basic protein-coupled spleen cells prevents experimental allergic encephalitis.
    Cell Immunol. 1983 Feb 1;75(2):378-82 PMID: 6187481
  11. The rapid isolation of clonable antigen-specific T lymphocyte lines capable of mediating autoimmune encephalomyelitis.
    Eur J Immunol. 1981 Mar;11(3):195-9 PMID: 6165588
  12. A genetically restricted suppressor factor that requires interaction with two distinct targets.
    J Immunol. 1984 Apr;132(4):1735-40 PMID: 6230392
  13. Studies on antigen-induced arthritis in mice. III. Cell and serum transfer experiments.
    J Immunol. 1977 May;118(5):1645-8 PMID: 300753
  14. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice.
    Arthritis Rheum. 1977 Apr;20(3):841-50 PMID: 857805
  15. Treatment of experimental allergic encephalomyelitis with encephalitogenic basic proteins.
    Proc Soc Exp Biol Med. 1972 Feb;139(2):506-10 PMID: 4621748
  16. Large scale preparation of myelin basic protein from central nervous tissue of several mammalian species.
    Prep Biochem. 1972;2(2):139-65 PMID: 4623901
  17. Infectious immunological tolerance.
    Immunology. 1971 Dec;21(6):903-14 PMID: 4943147
  18. Primary demyelination as a nonspecific consequence of a cell-mediated immune reaction.
    J Exp Med. 1975 Feb 1;141(2):346-59 PMID: 803545
  19. The production of arthritis in rabbits by an immunological reaction to fibrin.
    Br J Exp Pathol. 1962 Aug;43:373-83 PMID: 13888371
  20. On the mechanism of human T cell suppression.
    Int Immunol. 1989;1(2):121-9 PMID: 2535060
  21. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin antigens: IV. Suppression of chronic relapsing disease in the Lewis rat and strain 13 guinea pig.
    Ann Neurol. 1991 Jun;29(6):615-22 PMID: 1716432
  22. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. III. Synergistic effect of lipopolysaccharide.
    Cell Immunol. 1990 Dec;131(2):302-10 PMID: 1700738
  23. Suppression of adjuvant arthritis in Lewis rats by oral administration of type II collagen.
    J Immunol. 1990 Oct 15;145(8):2489-93 PMID: 2120332
  24. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein. II. Suppression of disease and in vitro immune responses is mediated by antigen-specific CD8+ T lymphocytes.
    J Immunol. 1989 Feb 1;142(3):748-52 PMID: 2464023
  25. Suppression of experimental autoimmune encephalomyelitis by the oral administration of myelin basic protein.
    Cell Immunol. 1988 Apr 1;112(2):364-70 PMID: 2451570
  26. Suppression of experimental autoimmune encephalomyelitis by oral administration of myelin basic protein and its fragments.
    J Immunol. 1988 Jan 15;140(2):440-5 PMID: 2447178
  27. Specific immune regulation of chronic-relapsing experimental allergic encephalomyelitis in mice.
    J Immunol. 1988 Nov 1;141(9):2986-93 PMID: 2459237
  28. Lymphokine activation of T4+ T lymphocytes and monocytes.
    J Immunol. 1987 Jun 1;138(11):3817-23 PMID: 3108375
  29. A nondeletional mechanism of thymic self tolerance.
    Science. 1989 Nov 24;246(4933):1038-41 PMID: 2511629
Article Info
Journal
The Journal of experimental medicine
Abbr.
J Exp Med
ISSN
0022-1007
Published
1991-10-01
Pages
791-8
Language
English
Region
United States
NLM ID
2985109R
PMCID
PMC2118953
Subset
IM
Grants
NCI NIH HHS · 1F05TWO4418, 1CP · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com